In light of these findings, our study further conducted an association analysis of gut microbiota with multiple indicators, confirming the utility of BL-99+FOS intervention in improving constipation mediated by multiple mechanisms, including regulation of gut microbiota composition and function, neurotransmitter synthesis, and inflammatory status. The gene discussed is FOS; the disease is constipation disorder.